$3.74 Billion is the total value of Hillhouse Capital Management's 50 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $942,432,000 | +12.0% | 5,472,259 | 0.0% | 25.19% | +75.7% | |
| JD | JD COM INCspon adr cl a | $553,424,000 | -33.0% | 21,212,125 | 0.0% | 14.79% | +5.0% | |
| ESGR | ENSTAR GROUP LIMITED | $364,425,000 | +0.6% | 1,747,840 | 0.0% | 9.74% | +57.7% | |
| FGEN | FIBROGEN INC | $163,186,000 | -3.0% | 2,686,196 | 0.0% | 4.36% | +52.2% | |
| MDLZ | MONDELEZ INTL INCcl a | $151,617,000 | +4.8% | 3,529,264 | 0.0% | 4.05% | +64.3% | |
| BPMC | BLUEPRINT MEDICINES CORP | $111,700,000 | +23.0% | 1,430,949 | 0.0% | 2.98% | +92.8% | |
| SNAP | SNAP INCcl a | $93,191,000 | -35.2% | 10,989,529 | 0.0% | 2.49% | +1.5% | |
| APLS | APELLIS PHARMACEUTICALS INC | $76,957,000 | -19.2% | 4,328,289 | 0.0% | 2.06% | +26.7% | |
| MYOK | MYOKARDIA INC | $55,964,000 | +31.3% | 858,340 | 0.0% | 1.50% | +106.1% | |
| KANG | IKANG HEALTHCARE GROUP INCsponsored adr | $52,903,000 | -11.5% | 2,922,834 | 0.0% | 1.41% | +38.8% | |
| LN | LINE CORPsponsored adr | $50,883,000 | +2.6% | 1,207,763 | 0.0% | 1.36% | +60.9% | |
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $16,320,000 | +13.5% | 51 | 0.0% | 0.44% | +78.0% | |
| SOHU | SOHU COM LTDsponsored ads | $15,944,000 | -44.0% | 802,034 | 0.0% | 0.43% | -12.2% | |
| MCO | MOODYS CORP | $15,039,000 | -2.0% | 89,949 | 0.0% | 0.40% | +54.0% | |
| VRSN | VERISIGN INC | $12,123,000 | +16.5% | 75,711 | 0.0% | 0.32% | +83.1% | |
| RCUS | ARCUS BIOSCIENCES INC | $10,694,000 | +13.9% | 767,128 | 0.0% | 0.29% | +78.8% | |
| GSAHU | GS ACQUISITION HLDGS CORPunit 06/12/2023 | $10,300,000 | +1.0% | 1,000,000 | 0.0% | 0.28% | +58.0% | |
| IDXX | IDEXX LABS INC | $8,334,000 | +14.6% | 33,380 | 0.0% | 0.22% | +79.8% | |
| CJJD | CHINA JO-JO DRUGSTORES INC | $7,792,000 | +11.8% | 4,840,000 | 0.0% | 0.21% | +74.8% | |
| SPGI | S&P GLOBAL INC | $4,765,000 | -4.2% | 24,387 | 0.0% | 0.13% | +49.4% | |
| SFUN | FANG HLDGS LTDadr | $3,885,000 | -33.2% | 1,500,000 | 0.0% | 0.10% | +5.1% | |
| EIDX | EIDOS THERAPEUTICS INC | $2,246,000 | -50.9% | 225,000 | 0.0% | 0.06% | -23.1% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $2,087,000 | -13.6% | 865,923 | 0.0% | 0.06% | +36.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.